For many people suffering with depression, NeuroStar® Advanced Therapy provides relief that traditional medications have failed to deliver. Take our quiz below to see if Neurostar® TMS is a good fit for you.
New Directions Mental Health is proud to partner with NeuroStar to provide Transcranial Magnetic Stimulation (TMS) as an option for our clients. TMS is a safe, effective, non-drug treatment for major depression without the common side effects of medication. It is approved by the FDA to treat depression and OCD in adolescents and adults.
Enrolling in NeuroStar® TMS treatment is the first step in taking control of your mental health journey. Our certified and experienced treatment teams are dedicated to providing you with the support and guidance you need to take charge of your mental well-being. Here’s how to get started:
You’ll recline comfortably in the treatment chair. A small, curved magnetic coil will be positioned lightly on your head. Our dedicated team members will help you through this process.
NeuroStar® delivers focused magnetic stimulation directly to the target areas of the brain. You’ll hear a clicking sound and feel a tapping sensation on your head, but don’t worry, for most patients, any pain or discomfort is only temporary and typically resolves within the first week of treatment.
NeuroStar® Advanced Therapy: Depending on your doctor’s recommendation. You can resume normal activities immediately. Because there are no effects on alertness or memory, you can drive yourself to and from treatment sessions. In-office treatment with NeuroStar® TMS Therapy typically takes 19-37 minutes and treatment takes place every day during the week for 7 weeks.
At New Directions Mental Health, we know you have a choice when you select your mental healthcare provider. Some of the reasons we are one of the best-known healthcare providers in Southwestern Pennsylvania are:
New Directions Mental Health is here to help no matter what you’re going through.
The NeuroStar® Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode. The NeuroStar® Advanced Therapy system is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD). NeuroStar® Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar® Advanced Therapy is right for you. Patients’ results may vary. Visit neurostar.com for full safety and prescribing information.
NeuroStar uses focused magnetic pulses (similar in strength to an MRI), to revitalize underactive areas of the brain involved in regulating mood. When these regions are underactive, depression can result. “Waking up” these regions can have a lasting effect on depression, making long-term remission from depression a reality for many people.
A study of real-world outcomes reported an 83% response rate which means patients experienced notable relief, and a 62% remission rate which means their depression effectively went away. The STAR*D study, the largest clinical trial of MDD ever conducted, showed that the rate of remission goes down with each new medication needed. If you’ve tried 3 or more medications, the chance of remission was just 7%.
Yes, TMS is a safe and FDA-approved depression treatment. More than 1.6 million NeuroStar® TMS therapy treatments have been performed, and less than five percent of clients reported any side effects. The most common side effect is a headache right after TMS treatment, which goes away after the first week of sessions for most people. Over 4.8 million NeuroStar® Advanced TMS treatments have been performed in over 134,000 patients.
Many patients experience side effects from their medication, increasing the chance that they will stop taking them. The most common side effect with NeuroStar® is mild to moderate pain or discomfort at the treatment site. For most patients this subsides within the first week of treatment.
Most major insurances cover NeuroStar® TMS, including Medicare plans nationwide.
Adults aged 22-70. Adolescents aged 15-21 are eligible for TMS as an add-on therapy.
NeuroStar® TMS is FDA-cleared for the treatment of Major Depressive Disorder (MDD) in adults 22-70, as an add-on therapy for adolescents aged 15-21, and for the treatment of Obsessive Compulsive Disorder (OCD) in adults aged 22-70.
Take the courageous first step toward a new chapter in your life. Reach out for mental health treatment in your area today by completing our brief questionnaire to connect with the compassionate professionals at New Directions Mental Health.
Meadowlands, PA
3000 Park Place Drive,
Suite 108
Washington, PA 15301
Monroeville, PA
4055 Monroeville Blvd
Monroeville, PA 15146
South Hills, PA
180 Fort Couch Road,
Suite 304
Pittsburgh, PA 15241
Wexford, PA – Stonewood
7000 Stonewood Drive,
Suite 300
Wexford, PA 15090
© Copyright 2023 Transformations Care Network